Baseline Characteristics of Atopic Dermatitis (AD) and AD Treatments in a Cohort of Adult AD Patients Initiating Dupilumab in a Real-World Registry (PROSE). J of Skin. 2020;4(6):s106. doi:10.25251/skin.4.supp.106